Crossmark

Incretin-based therapies in patients with pituitary disorders: clinical opportunity or premature enthusiasm? A balanced perspective

Crossref DOI link: https://doi.org/10.1007/s40618-026-02828-0

Published Online: 2026-02-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iglesias, Pedro https://orcid.org/0000-0003-0126-1985
License Information

Text and Data Mining valid from 2026-02-04

Version of Record valid from 2026-02-04
More Information

Article History

Received: 22 November 2025

Accepted: 23 January 2026

First Online: 4 February 2026

Declarations

:

: The author declare no conflicts of interest.